Brilliant Violet 421™ anti-mouse CD138 (Syndecan-1) Antibody

Pricing & Availability
Clone
281-2 (See other available formats)
Regulatory Status
RUO
Other Names
Syndecan-1
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
281-2_BV421_1_051812
C57BL/6 mouse bone marrow cells were stained with CD19 APC and CD138 (clone 281-2) Brilliant Violet 421™ (top) or rat IgG2a, κ Brilliant Violet 421™ isotype control (bottom). Data shown is from gated on lymphoid cell population.
  • 281-2_BV421_1_051812
    C57BL/6 mouse bone marrow cells were stained with CD19 APC and CD138 (clone 281-2) Brilliant Violet 421™ (top) or rat IgG2a, κ Brilliant Violet 421™ isotype control (bottom). Data shown is from gated on lymphoid cell population.
  • 281-2_BV421_2_051812
Compare all formats See Brilliant Violet 421™ spectral data
Cat # Size Price Quantity Check Availability Save
142507 125 µL 193 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
142523 50 µg 242 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
142508 500 µL 402 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD138, a member of the syndecan protein family, is a type I integral membrane heparin sulfate proteoglycan also known as Syndecan-1. Syndecan-1 participates in cell proliferation, cell migration, and cell matrix adhesion via interaction with collagen, fibronectin, and other soluble molecules (such as FGF-basic). It is expressed on normal and malignant plasma cells, pre-B cells, mesenchymal cells, epithelial cells, and endothelial cells.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse mammary gland epithelial cell line NMuMG
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation
The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 421™ under optimal conditions.
Concentration
µg sizes: 0.2 mg/mL
µL sizes: lot-specific (to obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.)
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining using the µg size, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. For flow cytometric staining using the µl sizes, the suggested use of this reagent is 5 µl per million cells in 100 µl staining volume or 5 µl per 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Brilliant Violet 421™ excites at 405 nm and emits at 421 nm. The standard bandpass filter 450/50 nm is recommended for detection. Brilliant Violet 421™ is a trademark of Sirigen Group Ltd.


Learn more about Brilliant Violet™.

This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents.
Excitation Laser
Violet Laser (405 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunohistochemical staining of frozen tissue3 and formalin-fixed paraffin embedded tissue4 and immunofluorescent staining2,3.

Application References

(PubMed link indicates BioLegend citation)
  1. Jalkanen M, et al. 1985. J. Cell. Biol. 101:976. (FC)
  2. Miettinen H, et al. 1994. J. Cell. Sci. 107:1571. (IF)
  3. Li Q, et al. 2002. Cell 111:635. (IF, IHC)
  4. McCarthy BA, et al. 2012. BMC Cancer. 12:203. (IHC)
Product Citations
  1. Hatzi K, et al. 2019. Nat Immunol. 20:86. PubMed
  2. Vono M, et al. 2020. Cell Reports. 28(7):1773-1784.e5.. PubMed
  3. Rivas MA, et al. 2021. Nat Immunol. 22:240. PubMed
  4. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  5. Gon Y, et al. 2023. PLoS One. 18:e0279389. PubMed
  6. Kodali S, et al. 2022. J Immunol. 208:1085. PubMed
  7. Daum P, et al. 2023. Front Immunol. 13:991347. PubMed
  8. Yazicioglu YF, et al. 2023. Nat Immunol. 24:991. PubMed
  9. Maschmeyer P, et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.11.005. PubMed
  10. Lino AC et al. 2018. Immunity. 49(1):120-133 . PubMed
  11. Rodda LB et al. 2018. Immunity. 48(5):1014-1028 . PubMed
  12. Farsakoglu Y et al. 2019. Cell reports. 26(9):2307-2315 . PubMed
  13. Baranek T, et al. 2020. Cell Reports. 32(10):108116. PubMed
  14. Pack AD, et al. 2021. Cell Reports. 36:109586. PubMed
  15. Huang L, et al. 2015. J Immunol. 194:283. PubMed
  16. Waide ML, et al. 2020. Cell Rep. 33:108503. PubMed
  17. Kenderes KJ, et al. 2018. Cell Rep. 24:824. PubMed
  18. Duan L, et al. 2021. Immunity. 54:2256. PubMed
  19. Mintz MA, et al. 2019. Immunity. 51:310. PubMed
  20. Ise W, et al. 2018. Immunity. 48:702. PubMed
  21. Qi T, et al. 2020. Cell Rep. 33:108452. PubMed
  22. Venturutti L, et al. 2020. Cell. 182(2):297-316.e27. PubMed
  23. Glaros V, et al. 2021. Immunity. 54:2005. PubMed
  24. Béguelin W, et al. 2020. Cancer Cell. 37(5):655-673. PubMed
  25. Schoeler K, et al. 2019. FEBS J. 10.1111/febs.14934. PubMed
  26. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  27. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  28. Kräutler NJ, et al. 2020. Cell Reports. 30(4):997-1012.e6.. PubMed
  29. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  30. Wang YH, et al. 2019. Front Immunol. 10:1909. PubMed
  31. He Z, et al. 2016. Exp Hematol. 44:161-165. PubMed
  32. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  33. Scally S, et al. 2017. Nat Commun. . 10.1038/s41467-017-01924-3. PubMed
  34. Mandal RK, et al. 2021. Cell Reports. 35(6):109094. PubMed
  35. Richardson ET, et al. 2015. PLoS One. 10: 1371. PubMed
  36. Haniuda K, et al. 2020. Cell Rep. 33:108333. PubMed
  37. Lazarian G, et al. 2021. Cancer Cell. 39(3):380-393.e8. PubMed
  38. Qi H, et al. 2020. Cell Reports. 31(6):107621. PubMed
  39. Kunishita Y, et al. 2020. Front Immunol. 11:98. PubMed
  40. Viant C, et al. 2020. Cell. 183:1298. PubMed
  41. Mesin L, et al. 2020. Cell. 180(1):92-106.e11.. PubMed
  42. Nascimento DC, et al. 2021. Immunity. :. PubMed
  43. Chen PM, et al. 2022. Sci Adv. 8:eabo4271. PubMed
  44. Trindade BC, et al. 2021. Immunity. 54:2273. PubMed
  45. Li X, et al. 2021. Front Immunol. 12:779560. PubMed
  46. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
RRID
AB_11204257 (BioLegend Cat. No. 142507)
AB_11204257 (BioLegend Cat. No. 142523)
AB_11204257 (BioLegend Cat. No. 142508)

Antigen Details

Structure
Transmembrane heparan sulfate proteoglycan; member of the syndecan proteoglycan family, 100-200 kD
Function
Cell adhesion, cell motility, cell migration, cell proliferation
Cell Type
B cells
Biology Area
Apoptosis/Tumor Suppressors/Cell Death, Cell Adhesion, Cell Biology, Cell Motility/Cytoskeleton/Structure, Immunology
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Zong F, et al. 2011. PLoS ONE 6:e14816.
2. Yamashita Y, et al. 1999. J. Immunol. 162:5940.
3. Sanderson RD, et al. 1989. Cell. Regul. 1:27.

Gene ID
20969 View all products for this Gene ID
UniProt
View information about CD138 on UniProt.org

Related FAQs

What is the F/P ratio range of our BV421™ format antibody reagents?

It is lot-specific. On average it ranges between 2-4.

Other Formats

View All CD138 Reagents Request Custom Conjugation
Description Clone Applications
Purified anti-mouse CD138 (Syndecan-1) 281-2 FC,ICC,IHC-P,IHC-F
PE anti-mouse CD138 (Syndecan-1) 281-2 FC
APC anti-mouse CD138 (Syndecan-1) 281-2 FC
Brilliant Violet 421™ anti-mouse CD138 (Syndecan-1) 281-2 FC
PerCP/Cyanine5.5 anti-mouse CD138 (Syndecan-1) 281-2 FC
Biotin anti-mouse CD138 (Syndecan-1) 281-2 FC
PE/Cyanine7 anti-mouse CD138 (Syndecan-1) 281-2 FC
Brilliant Violet 605™ anti-mouse CD138 (Syndecan-1) 281-2 FC
Brilliant Violet 650™ anti-mouse CD138 (Syndecan-1) 281-2 FC
Brilliant Violet 711™ anti-mouse CD138 (Syndecan-1) 281-2 FC
Brilliant Violet 510™ anti-mouse CD138 (Syndecan-1) 281-2 FC
Alexa Fluor® 647 anti-mouse CD138 (Syndecan-1) 281-2 FC
PE/Dazzle™ 594 anti-mouse CD138 (Syndecan-1) 281-2 FC
APC/Cyanine7 anti-mouse CD138 (Syndecan-1) 281-2 FC
TotalSeq™-A0810 anti-mouse CD138 (Syndecan-1) 281-2 PG
Brilliant Violet 785™ anti-mouse CD138 (Syndecan-1) 281-2 FC
TotalSeq™-C0810 anti-mouse CD138 (Syndecan-1) 281-2 PG
TotalSeq™-B0810 anti-mouse CD138 (Syndecan-1) 281-2 PG
PE/Cyanine5 anti-mouse CD138 (Syndecan-1) 281-2 FC
APC/Fire™ 750 anti-mouse CD138 (Syndecan-1) 281-2 FC
PE/Fire™ 640 anti-mouse CD138 (Syndecan-1) 281-2 FC
PE/Fire™ 810 anti-mouse CD138 (Syndecan-1) 281-2 FC
PE/Fire™ 700 anti-mouse CD138 (Syndecan-1) 281-2 FC
Spark Red™ 718 anti-mouse CD138 (Syndecan-1) (Flexi-Fluor™) 281-2 FC
Spark Blue™ 574 anti-mouse CD138 (Syndecan-1) (Flexi-Fluor™) 281-2 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account